Novo Nordisk's Alzheimer's Drug Trial Fails
Update: 2025-11-24
Description
Novo Nordisks Alzheimers drug trial fails, causing stock drop; company explored potential despite low success chance due to growing need for treatments as population ages.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
